rs34693334

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004525.3(LRP2):​c.775G>C​(p.Gly259Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0651 in 1,613,654 control chromosomes in the GnomAD database, including 4,153 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G259S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.056 ( 353 hom., cov: 31)
Exomes 𝑓: 0.066 ( 3800 hom. )

Consequence

LRP2
NM_004525.3 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.687

Publications

19 publications found
Variant links:
Genes affected
LRP2 (HGNC:6694): (LDL receptor related protein 2) The protein encoded by this gene, low density lipoprotein-related protein 2 (LRP2) or megalin, is a multi-ligand endocytic receptor that is expressed in many different tissues but primarily in absorptive epithilial tissues such as the kidney. This glycoprotein has a large amino-terminal extracellular domain, a single transmembrane domain, and a short carboxy-terminal cytoplasmic tail. The extracellular ligand-binding-domains bind diverse macromolecules including albumin, apolipoproteins B and E, and lipoprotein lipase. The LRP2 protein is critical for the reuptake of numerous ligands, including lipoproteins, sterols, vitamin-binding proteins, and hormones. This protein also has a role in cell-signaling; extracellular ligands include parathyroid horomones and the morphogen sonic hedgehog while cytosolic ligands include MAP kinase scaffold proteins and JNK interacting proteins. Recycling of this membrane receptor is regulated by phosphorylation of its cytoplasmic domain. Mutations in this gene cause Donnai-Barrow syndrome (DBS) and facio-oculoacoustico-renal syndrome (FOAR).[provided by RefSeq, Aug 2009]
LRP2 Gene-Disease associations (from GenCC):
  • Donnai-Barrow syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • Stickler syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017864704).
BP6
Variant 2-169290992-C-G is Benign according to our data. Variant chr2-169290992-C-G is described in ClinVar as [Benign]. Clinvar id is 129539.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0708 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRP2NM_004525.3 linkc.775G>C p.Gly259Arg missense_variant Exon 8 of 79 ENST00000649046.1 NP_004516.2 P98164Q7Z5C0Q7Z5C1
LRP2XM_011511183.4 linkc.775G>C p.Gly259Arg missense_variant Exon 8 of 78 XP_011509485.1
LRP2XM_047444340.1 linkc.-150G>C 5_prime_UTR_variant Exon 8 of 79 XP_047300296.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRP2ENST00000649046.1 linkc.775G>C p.Gly259Arg missense_variant Exon 8 of 79 NM_004525.3 ENSP00000496870.1 P98164
LRP2ENST00000443831.1 linkc.775G>C p.Gly259Arg missense_variant Exon 8 of 23 2 ENSP00000409813.1 E9PC35

Frequencies

GnomAD3 genomes
AF:
0.0557
AC:
8475
AN:
152048
Hom.:
354
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0203
Gnomad AMI
AF:
0.0429
Gnomad AMR
AF:
0.0492
Gnomad ASJ
AF:
0.181
Gnomad EAS
AF:
0.00116
Gnomad SAS
AF:
0.0772
Gnomad FIN
AF:
0.0874
Gnomad MID
AF:
0.143
Gnomad NFE
AF:
0.0697
Gnomad OTH
AF:
0.0621
GnomAD2 exomes
AF:
0.0637
AC:
15985
AN:
250840
AF XY:
0.0665
show subpopulations
Gnomad AFR exome
AF:
0.0210
Gnomad AMR exome
AF:
0.0345
Gnomad ASJ exome
AF:
0.179
Gnomad EAS exome
AF:
0.000979
Gnomad FIN exome
AF:
0.0832
Gnomad NFE exome
AF:
0.0691
Gnomad OTH exome
AF:
0.0827
GnomAD4 exome
AF:
0.0661
AC:
96590
AN:
1461488
Hom.:
3800
Cov.:
32
AF XY:
0.0677
AC XY:
49187
AN XY:
727040
show subpopulations
African (AFR)
AF:
0.0202
AC:
675
AN:
33468
American (AMR)
AF:
0.0367
AC:
1641
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.180
AC:
4715
AN:
26130
East Asian (EAS)
AF:
0.000504
AC:
20
AN:
39696
South Asian (SAS)
AF:
0.0854
AC:
7365
AN:
86218
European-Finnish (FIN)
AF:
0.0837
AC:
4469
AN:
53412
Middle Eastern (MID)
AF:
0.123
AC:
711
AN:
5764
European-Non Finnish (NFE)
AF:
0.0654
AC:
72724
AN:
1111704
Other (OTH)
AF:
0.0707
AC:
4270
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
4266
8531
12797
17062
21328
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2676
5352
8028
10704
13380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0557
AC:
8475
AN:
152166
Hom.:
353
Cov.:
31
AF XY:
0.0567
AC XY:
4214
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.0203
AC:
843
AN:
41536
American (AMR)
AF:
0.0492
AC:
752
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.181
AC:
629
AN:
3472
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5180
South Asian (SAS)
AF:
0.0773
AC:
371
AN:
4802
European-Finnish (FIN)
AF:
0.0874
AC:
924
AN:
10570
Middle Eastern (MID)
AF:
0.147
AC:
43
AN:
292
European-Non Finnish (NFE)
AF:
0.0697
AC:
4739
AN:
68000
Other (OTH)
AF:
0.0610
AC:
129
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
393
786
1180
1573
1966
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0698
Hom.:
388
Bravo
AF:
0.0510
TwinsUK
AF:
0.0677
AC:
251
ALSPAC
AF:
0.0636
AC:
245
ESP6500AA
AF:
0.0254
AC:
112
ESP6500EA
AF:
0.0707
AC:
608
ExAC
AF:
0.0630
AC:
7655
Asia WGS
AF:
0.0340
AC:
119
AN:
3478
EpiCase
AF:
0.0728
EpiControl
AF:
0.0741

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Donnai-Barrow syndrome Benign:2
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
9.4
DANN
Benign
0.44
DEOGEN2
Benign
0.068
T;T;T
Eigen
Benign
-0.98
Eigen_PC
Benign
-0.93
FATHMM_MKL
Benign
0.20
N
LIST_S2
Benign
0.20
.;T;T
MetaRNN
Benign
0.0018
T;T;T
MetaSVM
Benign
-0.75
T
MutationAssessor
Benign
-0.34
N;N;.
PhyloP100
0.69
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.20
.;N;N
REVEL
Benign
0.077
Sift
Benign
0.54
.;T;T
Sift4G
Uncertain
0.060
.;T;T
Polyphen
0.013
B;B;B
Vest4
0.080, 0.039
MPC
0.28
ClinPred
0.0018
T
GERP RS
2.7
Varity_R
0.030
gMVP
0.47
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34693334; hg19: chr2-170147502; COSMIC: COSV55539090; API